| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | 0.04 | 0.3 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | 0.045 | 0.3 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.3 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | navitoclax:PLX-4032 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |